Nov 19, 2024, 12:45 | Blog

ESMO - David Kerr's Historic Leadership that has Transformed Annals of Oncology

ESMO shared on LinkedIn: "Milestones Monday: In 2000, David Kerr succeeded Franco Cavalli to become the…

Nov 18, 2024, 16:31 | Insight

Andreas Koulouris: Incredible opportunity to participate in the Lung Cancer Preceptorship in Paris

Andreas Koulouris, Consultant in Oncology at Karolinska University Hospital, shared a post on X: “Grateful…

Nov 17, 2024, 23:37 | Blog

ESMO Women For Oncology Virtual Roadshow

ESMO shared on LinkedIn: "Building on the success of its first edition, the ESMO W4O Virtual…

Nov 16, 2024, 07:19 | Insight

Updated ESMO Clinical Practice Guideline on Cutaneous Melanoma

Marco Donia, Senior Consultant and Clinician-Scientist and Junior Research Group Leader at University of Copenhagen…

Nov 15, 2024, 21:03 | Insight

Explore the latest in oncology at ESMOASIA24

ESMO - European Society for Medical Oncology shared a post on LinkedIn: “Join us at…

Nov 15, 2024, 15:56 | Blog

Mark 35 years of Annals of Oncology with ESMO

ESMO shared on LinkedIn: "ESMO invites you to mark 35 years of Annals of Oncology. Over…

Nov 15, 2024, 07:03 | Blog

Factors enabling oncologists to cope with work-related stress - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "What factors enable…

Nov 13, 2024, 23:22 | Insight

Mireia Crispin on the emerging fields of application of AI tools

ESMO - European Society for Medical Oncology shared a post on LinkedIn: “The application of…

Nov 13, 2024, 15:56 | Blog

Jennifer Ivanovich: Thrilled to see the announcement of the new ESMO Rare Cancers journal

Jennifer Ivanovich, Genetic Counselor and Associate Professor of Oncology at Indiana University School of Medicine, shared on…

Nov 11, 2024, 18:59 | Blog

Mona Hassan: Excited to participate in the ESMO preceptorship for prostate cancer

Mona Hassan, Medical oncology Registrar at Portsmouth Hospitals University NHS Trust, posted on LinkedIn: "Very…

Nov 11, 2024, 02:47 | Insight

Erika Hamilton - Candidate for ASCO Nominating Committee

Erika Hamilton has been nominated as the Undesignated Member Candidate of the nomination committee for…

Nov 10, 2024, 18:31 | Insight

European Societies call EU to Not Lose Momentum to Tobacco Policy

European Cancer Organisation (ECO) shared on LinkedIn: “We are calling the EU to not lose…

Nov 10, 2024, 01:21 | Insight

Annalice Gandini: Genetic and transcriptomic analyses of early-onset colon cancer

Annalice Gandini, Medical oncologist resident at the Ospedale Policlinico San Martino in Genoa, shared her…

Nov 9, 2024, 10:17 | Blog

The European Society for Medical Oncology Preceptorship on Lung and Digestive Neuroendocrine Neoplasms

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "The ESMO Preceptorship on…

Nov 8, 2024, 19:11 | Blog

Bishal Gyawali: What oncologists and cancer patients perceive as meaningful benefit or justified prices

Bishal Gyawali shared on LinkedIn: "One of the most important global oncology cancer policy studies our…

Nov 8, 2024, 18:30 | Blog

Sami Mansfield: Elevating Quality of Life for Those Facing Lung Cancer

Sami (Papacek) Mansfield, Founder of Cancer Wellness for Life, shared a post on LinkedIn: ''Lifestyle…

Nov 8, 2024, 12:37 | Dialogues

Advancing Cancer Care: Shubh Goel on NIAGARA and Himalaya Trials

In this episode of OncoDaily, Shubh Goel, VP of Immuno-Oncology U.S. Franchise at AstraZeneca, discusses…

Nov 5, 2024, 15:32 | Blog

Carmen Criscitiello: SERENA-2 and INAVO120 offering fresh insights on targeted approaches in MBC

Carmen Criscitiello, Medical Oncologist at IEO and Associate Professor at University of Milan, posted on…

Nov 4, 2024, 15:21 | Insight

ctDNA shines a light on MRD in colorectal cancer - Oncology Advance

Oncology Advance shared a post on X about a recent paper by Huu-Thinh Nguyen et…

Nov 2, 2024, 17:53 | Blog

Last chance to register for ESMO Asia 2024 at discounted rates

ESMO - European Society for Medical Oncology, shared this post on LinkedIn: "Last chance to…

Nov 2, 2024, 12:01 | Positive

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…

Nov 1, 2024, 14:29 | Blog

Manchester Cancer Research Centre's highlights from ESMO Congress 24

Manchester Cancer Research Centre shared a post on X: "ICYMI from 13th- 17th Sept, MCRC reps…

Nov 1, 2024, 06:05 | Blog

Pawel Sobczuk about pharmaceutical wastage in the US on "One Health" column by ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: " The United States waste…

Oct 31, 2024, 16:55 | Blog

Innocent H. Peter Uggh: Ways we could improve our workforce’s mental health, wellbeing and resilience in LMICs

Innocent H. Peter Uggh, Study Coordinator and Research Scientist at Kilimanjaro Clinical Research Institute, posted…

Oct 31, 2024, 14:59 | Insight

pCR rates for patients with HR+/HER2 breast cancer - Annals of Oncology

Annals of Oncology shared a post on X about a recent paper by L.A. Huppert et…

Oct 30, 2024, 20:43 | Blog

How to become more sustainable in Daily Practice with the ESMO for Climate Portal

ESMO posted on LinkedIn: "Launched during the ESMO24 by the ESMO Climate Change Task Force,…

Oct 30, 2024, 19:33 | Blog

Pawel Sobczuk: ESMO Young Oncologists Committee is looking for new members

Pawel Sobczuk, Medical Oncology Fellow, Narodowy Instytut Onkologii, Warsaw, shared a post on X: "The…

Oct 30, 2024, 12:49 | Blog

Coral Olazagasti: Head and neck cancer updates at ESMO USA

Coral Olazagasti, Assistant professor at the Sylvester Cancer Center, shared on X: "Thank you Total…

Oct 29, 2024, 21:00 | Positive

Steven O'Day: At the Forefront of Immunotherapy

Dr. Steven O'Day, an immunotherapy pioneer and medical oncologist, is the Chief Medical Officer at…

Oct 29, 2024, 16:09 | Blog

How 4th generation EGFR TKI differ from third generation TKI? - article suggested by Amol Akhade

Amol Akhade, Consultant medical oncologist and Hemato-oncologist, Reliance Hospitals, shared a post on LinkedIn: "4th generation…

Oct 29, 2024, 15:23 | Blog

16th European Multidisciplinary Congress on Urological Cancers EMUC 2024

16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon, Portugal,…

Oct 28, 2024, 14:04 | Insight

Chandler Park: Update of the top data from the esophageal, gastric and colon cancers

Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared…

Oct 28, 2024, 13:46 | Insight

Lizzy Smyth: Happy to host the impressive Veronika Patsko as a ESMO fellow in Oxford

Lizzy Smyth, Medical Oncologist at Oxford University NHS Foundation Trust, shared a post on X:…

Oct 28, 2024, 12:46 | Blog

Lígia Melo McPherson: D2 ESMO EAST 2024 wrapped up with new trials on breast and prostate cancer

Lígia Melo McPherson, Medical Oncology RN at Mount Sinai Medical Center of Florida, shared following…

Oct 27, 2024, 13:54 | Blog

Evandro de Azambuja: Science evolves so does ESMO

Evandro de Azambuja, Director of Membership for the European Society for Medical Oncology (ESMO), shared…

Oct 26, 2024, 18:28 | Insight

SAGA Trial Achieves Full Recruitment: A Milestone in Cancer Research

The SAGA Trial has successfully completed full recruitment in just six months, marking a significant…

Oct 26, 2024, 10:46 | Blog

How is IVDR impacting your Cancer Research? - ESMO

The European Society for Medical Oncology (ESMO) shared a post on X: "How is IVDR…

Oct 26, 2024, 01:18 | Insight

How can Oncology Professionals navigate the challenges of the Digital Age?

ESMO - European Society for Medical Oncology shared on LinkedIn: “ESMO4Carers: How can Oncology Professionals…

Oct 23, 2024, 05:05 | Insight

Join SPCC’s live session for updates on the early and advanced lung cancer treatments presented at ESMO2024

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn: “Did you miss the…

Oct 22, 2024, 14:41 | Insight

Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma, summarised by Arndt Vogel

Arndt Vogel, Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School,…

Oct 21, 2024, 19:21 | Blog

ESMO E-Learning: Management of HER2-Low Breast Cancers by Paolo Tarantino

Paolo Tarantino shared a post on LinkedIn: ''Our understanding of HER2-low expression as a biomarker…

Oct 21, 2024, 19:06 | Blog

Sarah Louden: The Latest updates from ESMO at upcoming ESMO USA West

Sarah Louden, Founder and CEO of Total Health | Oncology, shared on LinkedIn: "ESMO USA West.…

Oct 21, 2024, 12:48 | Insight

An expert's take on colorectal cancer highlights

Oncology for the Inquisitive Mind shared a post on X: “With ESMO24 done, Michael and…

Oct 20, 2024, 11:13 | Blog

Implementation of the ESMO Guidelines in real clinical settings

ESMO shared a post on X: "Missed the live event? Watch the recording and download the…

Oct 20, 2024, 11:10 | Blog

The latest Kidney Cancer research from the ESMO conference - KidneyCAN

KidneyCAN shared a post on X: "The latest Kidney Cancer research from the ESMO conference…

Oct 19, 2024, 16:29 | Blog

Sequencing techniques have a wider range of applications in Cancer Treatment - ESMO

ESMO-European Society for Medical Oncology recently shared a post on LinkedIn: “Studies presented at MAP2024…

Oct 19, 2024, 16:22 | Societies

Highlights from MAP2024

The Molecular Analysis for Precision Oncology Congress 2024 (MAP2024) occurred from October 16 to 18,…

Oct 19, 2024, 08:19 | Insight

A global effort is essential to mitigate the risk of burnout and foster the well-being of the Oncology Workforce - ESMO

European Society for Medical Oncology (ESMO) shared a post by Fay Hlubocky, Research Proj. Prof,…

Oct 18, 2024, 15:13 | Blog

Studies presented at MAP2024 showcase the potential of CTCs, exo-miRNA, cfRNA in Cancer Detection and Progression Prediction - ESMO

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Three studies presented at…

Oct 16, 2024, 12:57 | Dialogues

Sarcoma Updates from ESMO 2024: Insights from Dr. Herbert Loong

Herbert Loong, Clinical Associate Professor in the Department of Clinical Oncology at the Chinese University…

Oct 15, 2024, 17:20 | Insight

A Croatian version of the ESMO Patient Guide on Bone Health in Cancer

ESMO - European Society for Medical Oncology made the following post on LinkedIn: “During the…

Oct 15, 2024, 16:57 | Blog

Ravindran Kanesvaran: A highly productive ESMO Advanced Course on ADC Development

Ravindran Kanesvaran, Chair and Senior Consultant, Division of Medical Oncology, National Cancer Centre Singapore, shared…

Oct 14, 2024, 12:36 | Insight

Updated data of KEYNOTE-716 and CheckMate 76K studies at ESMO24

The European Society for Medical Oncology (ESMO) shared a post on X: "At ESMO24, updated…

Oct 14, 2024, 11:40 | Insight

Characteristics and clinical outcomes of Breast Cancer in young BRCA carriers

Dana-Farber’s Breast Oncology Center shared a post on X: “New study now out in ESMO…

Oct 11, 2024, 13:44 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Fatima Cardoso

We are excited to introduce Dr. Fatima Cardoso, a prominent leader in breast cancer research…

Oct 10, 2024, 18:35 | Blog

Chandler Park: Enjoyed reviewing the data from the top GU oncologists from around the world at Uromigos Live 24

Chandler Park posted the following on LinkedIn: “Thank you Brian Rini, Tom Powles, The Uromigos…

Oct 10, 2024, 14:20 | Societies

Promising antitumour activity of new treatment modalities advanced solid tumours - ESMO

ESMO shared on LinkedIn: “Unleashing the power of immunotherapy in oncology is still challenging. While…

Oct 9, 2024, 15:55 | Blog

Amol Akhade: Perioperative chemo vs CTRT in GE Junction and Gastric Adenocarcinoma

Amol Akhade shared a post on LinkedIn: "Nice summary slide to show data for perioperative chemo…

Oct 9, 2024, 07:58 | Blog

Last chance to register for ESMO Immuno 24 in Geneva - ESMO

ESMO - European Society for Medical Oncology posted the following on LinkedIn: “ESMO Immuno 24:…

Oct 8, 2024, 10:55 | Blog

Aleix Prat: The high costs of anticancer therapies in the USA

Aleix Prat shared the following on X: “The high costs of anticancer therapies in the…

Oct 8, 2024, 09:36 | Blog

Elene Kekelia: Incredible Opportunity To Present A Clinical Case On Breast Cancer During The Pink October

Elene Kekelia, Medical Oncology Resident at Tbilisi Medical Academy after Petre Shotadze, shared a post on…

Oct 7, 2024, 14:48 | Blog

ESMO Targeted Anticancer Therapies Congress 2025

Join us for the ESMO Targeted Anticancer Therapies Congress 2025, taking place on March 3-5…

Oct 7, 2024, 12:47 | Blog

Flavia Jacobs: Great advanced ESMO course on Antibody-Drug Conjugates

Flavia Jacobs, Medical Research Fellow at Institute Jules Bordet, recently shared on LinkedIn: "Great advanced…

Oct 7, 2024, 12:24 | Blog

Lizzy Smyth: ESMO first ADC Advanced Course

Lizzy Smyth, Consultant Medical Oncologist in Upper GI Oncology at Oxford University, shared on X:…

Oct 7, 2024, 09:18 | Blog

Dario Trapani: Addressing global challenges in cancer control for 1 community in 1 world at ESMO

Dario Trapani shared a post on X: “Can’t be more grateful to The European Society for Medical…

Oct 7, 2024, 09:14 | Blog

Khoren Amirkhanyan: Participated in two enriching programs by ESMO

Khoren Amirkhanyan, Oncology Resident, National Center of Oncology of Armenia, shared a post on LinkedIn:…

Oct 7, 2024, 06:50 | Blog

Lazar Popovic: Great pleasure to speak in ESMO preceptorships

Lazar Popovic, Professor of Oncology at the Oncology Institute of Vojvodina, shared on LinkedIn: "When…

Oct 6, 2024, 17:42 | Blog

Matthew Kurian: Join me on October 18-19th in Louisville, KY for the 2024 KYSCO Annual Cancer Symposium!

Matthew Kurian, Staff Oncologist at St. Elizabeth Healthcare, shared a post on LinkedIn: “Join me…

Oct 6, 2024, 17:29 | Blog

Lizzy Smyth: Privileged to co-chair the first ESMO ADC Advanced Course with Giuseppe Curigliano

Lizzy Smyth shared a post on X by Alberto Puccini, adding: "What a privilege to…

Oct 5, 2024, 16:19 | Blog

Enrique Grande: How many challenges in GU tumors to try to address in the upcoming years?

Petros Grivas shared a post on X: "Adding a few recent Grivas Selfie examples for friends…

Oct 5, 2024, 10:59 | Blog

Diogo Martins Branco: ESMO Reimbursement Model

Diogo Martins Branco, Medical Oncologist at ESMO, posted on LinkedIn: "ESMO - European Society for Medical…

Oct 5, 2024, 09:09 | Insight

Sunil Verma: AstraZeneca’s vision to redefine cancer care

Sunil Verma shared on LinkedIn: “ I had the pleasure of sitting down with Hannah…

Oct 4, 2024, 15:10 | Blog

The ESMO Gastric Cancer Living Guideline and Slide Set are updated

The European Society for Medical Oncology shared a post on X: "The ESMO Gastric Cancer…

Oct 3, 2024, 18:09 | Blog

Presidential Highlight from ESMO 2024

Elisa Agostinetto shared a post by MediMix on LinkedIn, adding: "At ESMO24 the practice-changing results of the HypoG-01…

Oct 3, 2024, 18:00 | Insight

Amol Akhade: How to manage rare endocrine and Neuroendocrine Tumors

Amol Akhade shared a post on LinkedIn: "How to manage rare endocrine and Neuroendocrine Tumors.…

Oct 3, 2024, 13:00 | Positive

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…

Oct 3, 2024, 07:42 | Societies

The early registration deadline for ESMO Immuno24 is fast approaching

ESMO shared on LinkedIn: "ESMO Immuno24: The early registration deadline is fast approaching! Connect with…

Oct 3, 2024, 07:05 | Blog

New ESMO Clinical Practice Guideline on Rare Endocrine Tumors

ESMO posted on LinkedIn: "New ESMO Clinical Practice Guideline on Rare Endocrine Tumors: Evidence-based recommendations…

Oct 1, 2024, 13:23 | Blog

Zainab Shinkafi-Bagudu's dedication to raising awareness and improving access to care for underserved populations is deeply inspiring - EAPM

Zainab Shinkafi-Bagudu shared a post by European Alliance for Personalised Medicine (EAPM) on LinkedIn, adding:…

Oct 1, 2024, 09:55 | Blog

María Natalia Gandur Quiroga: Promising Outcomes for Pazopanib Plus Bevacizumab in Clear Cell RCC

María Natalia Gandur Quiroga posted on X: "Promising Outcomes for Pazopanib Plus Bevacizumab in Clear…

Oct 1, 2024, 09:29 | Blog

Paolo Tarantino's ESMO24 top 5 breast cancer presentations and takeaway messages

Paolo Tarantino shared a post by Sameh Abdelmalak, Director, Oncology, Educational Partnerships at VuMedi, on X, adding:…

Oct 1, 2024, 08:28 | Blog

Daniel Michaeli: Key takeaways from our new article on breast cancer drugs

Daniel Michaeli shared a post on LinkedIn, about a recently published paper: Breast cancer drugs:…

Sep 30, 2024, 16:12 | Blog

Triparna Sen: Honored to participate in the Lung Cancer America patient advocacy workshop

Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on X:…

Sep 30, 2024, 14:33 | Blog

Hidehito Horinouchi: Welcoming participants from Korea and around the world to Kobe

Hidehito Horinouchi shared a post on X: ''KSMO2024, JSMO2025 booth We welcome korean and world…

Sep 29, 2024, 15:24 | Blog

Vivek Subbiah: "Bringing the Best Minds Together to Tackle Cancer" at the United Nations General Assembly

Vivek Subbiah shared a post on LinkedIn: "I was deeply honored and excited to have…

Sep 28, 2024, 15:56 | Blog

Yasmine Hassan: Liver cancer is the 6th most common cancer worldwide

Yasmine Hassan, Global Patient Affairs Director at AstraZeneca, shared the following on LinkedIn: “Liver cancer is…

Sep 28, 2024, 05:16 | Career

David Kerr Is Running For The UICC Board of Directors

David Kerr, Professor of cancer medicine at the University of Oxford in England, is running…

Sep 27, 2024, 16:34 | Blog

Explore groundbreaking cancer research at ESMO 2024

ESMO - European Society for Medical Oncology shared on LinkedIn: “Explore the latest cutting-edge scientific…

Sep 27, 2024, 16:31 | Insight

Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute

The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…

Sep 27, 2024, 15:09 | Blog

Oncogene-addicted NSCLC highlights from WCLC24 and ESMO24 - Lung Connect

Herbert Loong shared a post by LUNG CONNECT on LinkedIn, adding: "Thanks LUNG CONNECT for providing me w/…

Sep 26, 2024, 17:57 | Insight

Results from the ABIGAIL study presented at ESMO24

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "At ESMO24 results…

Sep 26, 2024, 17:20 | Societies

The start of ESMO in the Alps 2024 - Swiss Group for Clinical Cancer Research

Swiss Group for Clinical Cancer Research (SAKK) shared a post on LinkedIn: "Today marks the…

Sep 25, 2024, 15:58 | Blog

ESMO 2024: Precision Oncology and the Future of Molecular Prevention - MediaMedic

MediaMedic shared a post on LinkedIn about MediaMedic article, adding: "ESMO 2024: Precision Oncology and…

Sep 25, 2024, 15:17 | Blog

Bishal Gyawali: My talk at the Common Sense Oncology symposium during ESMO24 is now available

Bishal Gyawali shared on X: "Recording from my talk at the Common Sense Oncology symposium…

Sep 24, 2024, 23:13 | Blog

Sami Mansfield: Final ASCO2024 summer event is wrapped up

Sami Mansfield shared a post on LinkedIn: ''Final ASCO2024 summer event is wrapped up! What…

Sep 24, 2024, 22:41 | Insight

Paolo Tarantino: What percentage of our patients with ER+/HER2- eBC may qualify for adjuvant CDK4/6i?

Paolo Tarantino shared a post on X: "Now that adjuvant ribociclib is approved, what %…

Sep 24, 2024, 20:17 | Blog

Robin Zon: Sharing ASCO State of the union at Texas Oncology state affiliate

Robin Zon shared a post on LinkedIn: "Thank you to Texas Oncology state affiliate for inviting…

Sep 24, 2024, 17:11 | Blog

Guru Sonpavde: ESMO24 bladder cancer highlight HRQoL outcomes from CheckMate 901 trial

Guru Sonpavde shared a post on LinkedIn: "ESMO24 bladder cancer highlight: Health-related quality of life (HRQoL)…

Sep 24, 2024, 12:30 | Societies

11 ESMO24 presentations published on NEJM

At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…

Sep 24, 2024, 09:07 | Blog

Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer

Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto,…